Palo Alto Investors LP Long-Term Concentrated

Location: Palo Alto, CA

CIK: 0001306923 · Show all filings

Period: Q3 2019 (← Previous) (Next →)

Filing Date: Nov 14, 2019

Total Value: $1.501B (100.0% shares, 0.0% debt)

Holdings (37)

BMRN BIOMARIN PHARMACEUTICAL INC 9.9%
Value $149M Shares 2,209,504 Share Price $67.40 * Est. Cost/Share $80.19 Unrealized @ Report Date -3.9%
INSM INSMED INC 8.5%
Value $128M Shares 7,239,649 Share Price $17.64 * Est. Cost/Share $17.16 Unrealized @ Report Date +12.5%
— ABIOMED INC 7.8%
Value $116M Shares 654,428 Share Price $177.89 Est. Cost/Share $37.80 Unrealized @ Report Date —
UTHR UNITED THERAPEUTICS CORP 7.6%
Value $114M Shares 1,424,401 Share Price $79.75 Est. Cost/Share $88.73 Unrealized @ Report Date -9.2%
STAA STAAR SURGICAL CO 6.7%
Value $100M Shares 3,890,693 Share Price $25.78 * Est. Cost/Share $13.06 Unrealized @ Report Date +132.7%
— SAGE THERAPEUTICS INC 6.4%
Value $95.52M Shares 680,894 Share Price $140.29 Est. Cost/Share $48.62 Unrealized @ Report Date —
— ALEXION PHARMACEUTICALS INC 6.2%
Value $93.82M Shares 957,950 Share Price $97.94 Est. Cost/Share $121.54 Unrealized @ Report Date —
— IMMUNOMEDICS INC 5.5%
Value $82M Shares 6,184,320 Share Price $13.26 Est. Cost/Share $13.38 Unrealized @ Report Date —
ACAD ACADIA PHARMACEUTICALS INC 5.2%
Value $78.34M Shares 2,176,677 Share Price $35.99 * Est. Cost/Share $27.34 Unrealized @ Report Date +10.9%
— AIMMUNE THERAPEUTICS INC 4.8%
Value $72.7M Shares 3,471,740 Share Price $20.94 Est. Cost/Share $22.84 Unrealized @ Report Date —
— EPIZYME INC 4.4%
Value $65.55M Shares 6,354,659 Share Price $10.31 Est. Cost/Share $15.12 Unrealized @ Report Date —
VNDA VANDA PHARMACEUTICALS INC 4.1%
Value $60.84M Shares 4,581,176 Share Price $13.28 * Est. Cost/Share $11.21 Unrealized @ Report Date +24.3%
FOLD AMICUS THERAPEUTICS INC 3.8%
Value $57.45M Shares 7,162,920 Share Price $8.02 * Est. Cost/Share $7.54 Unrealized @ Report Date +44.0%
— WRIGHT MEDICAL GROUP NV 3.4%
Value $51.46M Shares 2,494,255 Share Price $20.63 Est. Cost/Share $23.42 Unrealized @ Report Date —
— KARYOPHARM THERAPEUTICS INC 3.1%
Value $46.58M Shares 4,842,150 Share Price $9.62 Est. Cost/Share $17.42 Unrealized @ Report Date —
— AMAG PHARMACEUTICALS INC 2.4%
Value $35.56M Shares 3,078,874 Share Price $11.55 Est. Cost/Share $29.07 Unrealized @ Report Date —
— ALDER BIOPHARMACEUTICALS INC 2.3%
Value $35.11M Shares 1,861,630 Share Price $18.86 Est. Cost/Share $11.48 Unrealized @ Report Date —
ALGN ALIGN TECHNOLOGY INC 1.8%
Value $26.69M Shares 147,505 Share Price $180.92 * Est. Cost/Share $114.31 Unrealized @ Report Date +81.9%
— MOMENTA PHARMACEUTICALS INC 1.5%
Value $22.77M Shares 1,757,122 Share Price $12.96 Est. Cost/Share $14.06 Unrealized @ Report Date —
— CLOVIS ONCOLOGY INC 1.2%
Value $18.55M Shares 4,720,744 Share Price $3.93 Est. Cost/Share $51.30 Unrealized @ Report Date —
PBYI PUMA BIOTECHNOLOGY INC 1.0%
Value $15.13M Shares 1,405,680 Share Price $10.76 Est. Cost/Share $28.90 Unrealized @ Report Date -62.6%
PRTA PROTHENA CORP PLC 0.5%
Value $7.875M Shares 1,004,449 Share Price $7.84 * Est. Cost/Share $32.98 Unrealized @ Report Date -73.1%
— RIGEL PHARMACEUTICALS INC 0.4%
Value $6.708M Shares 3,587,351 Share Price $1.87 Est. Cost/Share $3.40 Unrealized @ Report Date —
KLDO KALEIDO BIOSCIENCES INC 0.4%
Value $5.934M Shares 787,999 Share Price $7.53 * Est. Cost/Share $13.76 Unrealized @ Report Date -36.9%
— DICERNA PHARMACEUTICALS INC 0.3%
Value $4.765M Shares 331,813 Share Price $14.36 Est. Cost/Share $5.39 Unrealized @ Report Date —
GILD GILEAD SCIENCES INC 0.2%
Value $2.491M Shares 39,300 Share Price $63.38 * Est. Cost/Share $62.02 Unrealized @ Report Date -17.8%
— CELGENE CORP 0.1%
Value $2.173M Shares 21,883 Share Price $99.30 Est. Cost/Share $89.02 Unrealized @ Report Date —
— ALIMERA SCIENCES INC 0.1%
Value $1.707M Shares 3,013,793 Share Price $0.57 Est. Cost/Share $4.88 Unrealized @ Report Date —
CYTK CYTOKINETICS INC 0.1%
Value $1.408M Shares 123,686 Share Price $11.38 * Est. Cost/Share $6.71 Unrealized @ Report Date +87.0%
— ZOGENIX INC 0.1%
Value $1.181M Shares 29,500 Share Price $40.03 Est. Cost/Share $13.36 Unrealized @ Report Date —
— SUNESIS PHARMACEUTICALS INC 0.1%
Value $837K Shares 1,162,473 Share Price $0.72 Est. Cost/Share $4.37 Unrealized @ Report Date —
ALDX ALDEYRA THERAPEUTICS INC 0.0%
Value $387K Shares 73,500 Share Price $5.27 * Est. Cost/Share $7.53 Unrealized @ Report Date -28.5%
— MINERVA NEUROSCIENCES INC 0.0%
Value $281K Shares 36,319 Share Price $7.74 Est. Cost/Share $5.62 Unrealized @ Report Date —
— IDERA PHARMACEUTICALS INC 0.0%
Value $223K Shares 77,044 Share Price $2.89 Est. Cost/Share $8.90 Unrealized @ Report Date —
— MARINUS PHARMACEUTICALS INC 0.0%
Value $193K Shares 125,321 Share Price $1.54 Est. Cost/Share $4.17 Unrealized @ Report Date —
— SOPHIRIS BIO INC 0.0%
Value $144K Shares 247,000 Share Price $0.58 Est. Cost/Share $2.60 Unrealized @ Report Date —
— MELINTA THERAPEUTICS INC 0.0%
Value $39,000 Shares 10,137 Share Price $3.85 Est. Cost/Share $3.55 Unrealized @ Report Date —